sobuzoxane has been researched along with Recrudescence in 4 studies
sobuzoxane: used in treatment of leukemia L1210
| Excerpt | Relevance | Reference |
|---|---|---|
| " On the basis of the synergistic activity in preclinical studies and the schedule dependency in these drugs, low-dose and long-term administration was planned." | 2.68 | Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16. MST-16 Study Group. ( Ariyoshi, Y; Furue, H; Horiuchi, A; Kagami, Y; Kanamaru, A; Kano, Y; Masaoka, T; Naoe, T; Oguro, M; Ohno, R; Sampi, K; Shirakawa, S, 1996) |
| "We report here a Japanese female with follicular lymphoma who subsequently developed PML." | 1.31 | Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma. ( Daibata, M; Hatakeyama, N; Hiroi, M; Kamioka, M; Miyoshi, I; Nemoto, Y; Taguchi, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, M | 1 |
| Tsunoda, S | 1 |
| Koyama, D | 1 |
| Ikeda, S | 1 |
| Sukegawa, M | 1 |
| Hojo, H | 1 |
| Ohta, M | 1 |
| Kagami, Y | 1 |
| Ariyoshi, Y | 1 |
| Horiuchi, A | 1 |
| Kanamaru, A | 1 |
| Kano, Y | 1 |
| Naoe, T | 1 |
| Oguro, M | 1 |
| Ohno, R | 1 |
| Sampi, K | 1 |
| Shirakawa, S | 1 |
| Masaoka, T | 1 |
| Furue, H | 1 |
| Okamoto, T | 1 |
| Nishimura, Y | 1 |
| Yamada, S | 2 |
| Itoh, T | 1 |
| Mori, A | 1 |
| Saheki, K | 1 |
| Okada, M | 1 |
| Takatsuka, H | 1 |
| Wada, H | 1 |
| Tamura, A | 1 |
| Fujimori, Y | 1 |
| Kakishita, E | 1 |
| Daibata, M | 1 |
| Hatakeyama, N | 1 |
| Kamioka, M | 1 |
| Nemoto, Y | 1 |
| Hiroi, M | 1 |
| Miyoshi, I | 1 |
| Taguchi, H | 1 |
1 trial available for sobuzoxane and Recrudescence
| Article | Year |
|---|---|
Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16. MST-16 Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Adm | 1996 |
3 other studies available for sobuzoxane and Recrudescence
| Article | Year |
|---|---|
MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistanc | 2021 |
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 2000 |
Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; DNA, Vira | 2001 |